Advances in research on the anti-tumor mechanism of Astragalus polysaccharides

被引：16

作者：

Yang, Qian ^{[1
]}

Meng, Dandan ^{[1
]}

Zhang, Qinyuan ^{[1
]}

Wang, Jin ^{[1
]}

机构：

[1] Shandong Univ Tradit Chinese Med, Sch Chinese Med, Jinan, Peoples R China

来源：

FRONTIERS IN ONCOLOGY | 2024年 / 14卷

关键词：

Astragalus polysaccharides; anti-tumor therapy; cancer; anti-tumor mechanism; apoptosis; autophagy; MIGRATION INHIBITORY FACTOR; CELL-CYCLE; SELENIUM NANOPARTICLES; MESENCHYMAL TRANSITION; CISPLATIN RESISTANCE; MOLECULAR-MECHANISMS; THERAPEUTIC TARGET; EPITHELIAL-CELLS; LIPID-METABOLISM; CANCER-CELLS;

D O I：

10.3389/fonc.2024.1334915

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The dry root of the soybean plant Astragalus membranaceus (Fisch) Bge. var. mongholicus (Bge) Hsiao or A. membranaceus (Fisch) Bge, Astragali Radix (AR) has a long medicinal history. Astragalus polysaccharide (APS), the natural macromolecule that exhibits immune regulatory, anti-inflammatory, anti-tumor, and other pharmacological activities, is an important active ingredient extracted from AR. Recently, APS has been increasingly used in cancer therapy owing to its anti-tumor ability as it prevents the progression of prostate, liver, cervical, ovarian, and non-small-cell lung cancer by suppressing tumor cell growth and invasion and enhancing apoptosis. In addition, APS enhances the sensitivity of tumors to antineoplastic agents and improves the body's immunity. This macromolecule has prospects for broad application in tumor therapy through various pathways. In this article, we present the latest progress in the research on the anti-tumor effects of APS and its underlying mechanisms, aiming to provide novel theoretical support and reference for its use in cancer therapy.

引用

页数：14